Impact of One-Health framework on vaccination cost-effectiveness: A case study of rabies in Ethiopia

被引:8
作者
Beyene, Tariku Jibat [1 ,2 ]
Fitzpatrick, Meagan C. [3 ,4 ]
Galvani, Alison P. [4 ]
Mourits, Monique C. M. [5 ]
Revie, Crawford W. [6 ,7 ]
Cernicchiaro, Natalia [1 ]
Sanderson, Michael W. [1 ]
Hogeveen, Henk [5 ,8 ]
机构
[1] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Outcomes Res & Epidemiol, Manhattan, KS 66506 USA
[2] Addis Ababa Univ, Coll Vet Med & Agr, Debre Zeit, Ethiopia
[3] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA
[4] Yale Univ, Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06510 USA
[5] Wageningen Univ, Business Econ Grp, Hollandseweg 1, NL-6706 KN Wageningen, Netherlands
[6] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, 550 Univ Ave, Charlottetown, PE C1A 4P3, Canada
[7] Univ Strathclyde, Dept Comp & Informat Sci, Glasgow G1 1XQ, Lanark, Scotland
[8] Univ Utrecht, Dept Farm Anim Hlth, Fac Vet Med, Utrecht, Netherlands
关键词
Cost-effectiveness; Ethiopia; Modeling; One-health; Rabies; CANINE RABIES; ECONOMICS; EPIDEMIOLOGY; ELIMINATION; STRATEGIES; DISEASE; DOGS;
D O I
10.1016/j.onehlt.2019.100103
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Livestock losses due to rabies and health and the corresponding benefits of controlling the disease are not often considered when the cost-effectiveness of rabies control is evaluated. In this research, assessed the benefits of applying a One Health perspective that includes these losses to the case of canine rabies vaccination in Ethiopia. We constructed a dynamic epidemiological model of rabies transmission. The model was fit to district-specific data on human rabies exposures and canine demography for two districts with distinct agro-ecologies. The epidemiological model was coupled with human and livestock economic outcomes to predict the health and economic impacts under a range of vaccination scenarios. The model indicates that human exposures, human deaths, and rabies-related livestock losses would decrease monotonically with increasing vaccination coverage. In the rural district, all vaccination scenarios were found to be cost-saving compared to the status quo of no vaccination, as more money could be saved by preventing livestock losses than would be required to fund the vaccination campaigns. Vaccination coverages of 70% and 80% were identified as most likely to provide the greatest net health benefits at the WHO cost-effectiveness threshold over a period of 5 years, in urban and rural districts respectively. Shorter time frames led to recommendations for higher coverage in both districts, as did even a minor threat of rabies re-introduction. Exclusion of rabies-related livestock losses reduced the optimal vaccination coverage for the rural district to 50%. This study demonstrated the importance of including all economic consequences of zoonotic disease into control decisions. Analyses that include cattle and other rabies-susceptible livestock are likely better suited to many rural communities in Africa wishing to maximize the benefits of canine vaccination.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led
    Diop, Abdou
    Atherly, Deborah
    Faye, Alioune
    Sall, Farba Lamine
    Clark, Andrew D.
    Nadiel, Leon
    Yade, Binetou
    Ndiaye, Mamadou
    Cisse, Moussa Fafa
    Ba, Mamadou
    VACCINE, 2015, 33 : A119 - A125
  • [42] Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China
    Liu, Na
    Yen, Catherine
    Fang, Zhao-yin
    Tate, Jacqueline E.
    Jiang, Baoming
    Parashar, Umesh D.
    Zeng, Guang
    Duan, Zhao-jun
    VACCINE, 2012, 30 (48) : 6940 - 6945
  • [43] An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany
    Largeron, Nathalie
    Petry, Karl Ulrich
    Jacob, Jorge
    Bianic, Florence
    Anger, Delphine
    Uhart, Mathieu
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (01) : 85 - 98
  • [44] Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
    Orangi, Stacey
    Ojal, John
    Brand, Samuel P. C.
    Orlendo, Cameline
    Kairu, Angela
    Aziza, Rabia
    Ogero, Morris
    Agweyu, Ambrose
    Warimwe, George M.
    Uyoga, Sophie
    Otieno, Edward
    Ochola-Oyier, Lynette, I
    Agoti, Charles N.
    Kasera, Kadondi
    Amoth, Patrick
    Mwangangi, Mercy
    Aman, Rashid
    Ng'ang'a, Wangari
    Adetifa, Ifedayo M. O.
    Scott, J. Anthony G.
    Bejon, Philip
    Keeling, Matt J.
    Flasche, Stefan
    Nokes, D. James
    Barasa, Edwine
    BMJ GLOBAL HEALTH, 2022, 7 (08):
  • [45] Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis
    Bresse, Xavier
    Goergen, Christoph
    Prager, Bernhard
    Joura, Elmar
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (02) : 269 - 281
  • [46] The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study
    Melegaro, Alessia
    Marziano, Valentina
    Del Fava, Emanuele
    Poletti, Piero
    Tirani, Marcello
    Rizzo, Caterina
    Merler, Stefano
    BMC MEDICINE, 2018, 16
  • [47] Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain
    Linertova, Renata
    Guirado-Fuentes, Carmen
    Mar-Medina, Javier
    Teljeur, Conor
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [48] Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study
    Quezada, Arnoldo
    Baron-Papillon, Florence
    Coudeville, Laurent
    Maggi, Leonardo
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2008, 23 (05): : 303 - 312
  • [49] Economic Impact of Dengue Illness and the Cost-Effectiveness of Future Vaccination Programs in Singapore
    Carrasco, Luis R.
    Lee, Linda K.
    Lee, Vernon J.
    Ooi, Eng Eong
    Shepard, Donald S.
    Thein, Tun L.
    Gan, Victor
    Cook, Alex R.
    Lye, David
    Ng, Lee Ching
    Leo, Yee Sin
    PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (12):
  • [50] Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination
    Quinn, Emma
    Jit, Mark
    Newall, Anthony T.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (03) : 425 - 435